CStone Pharmaceuticals Salute del bilancio
Salute finanziaria criteri di controllo 5/6
CStone Pharmaceuticals has a total shareholder equity of CN¥467.7M and total debt of CN¥306.4M, which brings its debt-to-equity ratio to 65.5%. Its total assets and total liabilities are CN¥1.5B and CN¥1.1B respectively.
Informazioni chiave
65.5%
Rapporto debito/patrimonio netto
CN¥306.42m
Debito
Indice di copertura degli interessi | n/a |
Contanti | CN¥857.65m |
Patrimonio netto | CN¥467.66m |
Totale passività | CN¥1.06b |
Totale attività | CN¥1.53b |
Aggiornamenti recenti sulla salute finanziaria
Is CStone Pharmaceuticals (HKG:2616) A Risky Investment?
Oct 03Is CStone Pharmaceuticals (HKG:2616) A Risky Investment?
Oct 20Is CStone Pharmaceuticals (HKG:2616) Using Too Much Debt?
Dec 17Recent updates
There's No Escaping CStone Pharmaceuticals' (HKG:2616) Muted Revenues Despite A 29% Share Price Rise
Oct 04Improved Revenues Required Before CStone Pharmaceuticals (HKG:2616) Stock's 27% Jump Looks Justified
May 12Lacklustre Performance Is Driving CStone Pharmaceuticals' (HKG:2616) 28% Price Drop
Mar 04Benign Growth For CStone Pharmaceuticals (HKG:2616) Underpins Stock's 25% Plummet
Jan 18The Market Doesn't Like What It Sees From CStone Pharmaceuticals' (HKG:2616) Revenues Yet As Shares Tumble 26%
Oct 04Is CStone Pharmaceuticals (HKG:2616) A Risky Investment?
Oct 03Is CStone Pharmaceuticals (HKG:2616) A Risky Investment?
Oct 20Is CStone Pharmaceuticals (HKG:2616) Using Too Much Debt?
Dec 17Analisi della posizione finanziaria
Passività a breve termine: 2616's short term assets (CN¥1.2B) exceed its short term liabilities (CN¥713.2M).
Passività a lungo termine: 2616's short term assets (CN¥1.2B) exceed its long term liabilities (CN¥351.2M).
Storia e analisi del rapporto debito/patrimonio netto
Livello di debito: 2616 has more cash than its total debt.
Riduzione del debito: 2616's debt to equity ratio has increased from 0% to 65.5% over the past 5 years.
Bilancio
Analisi della pista di contanti
Per le società che in passato sono state mediamente in perdita, valutiamo se hanno almeno un anno di liquidità.
Pista di liquidità stabile: 2616 has sufficient cash runway for more than 3 years based on its current free cash flow.
Previsione Cash Runway: 2616 has sufficient cash runway for 1.7 years if free cash flow continues to grow at historical rates of 8.1% each year.